Clinical Trials Logo

Acneiform Eruptions clinical trials

View clinical trials related to Acneiform Eruptions.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04697069 Terminated - Acneiform Eruptions Clinical Trials

A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash

Start date: May 4, 2021
Phase: Phase 2
Study type: Interventional

Efficacy and Safety of imsidolimab in participants with epidermal growth factor receptor inhibitor (EGFRi)/mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase inhibitor (MEKi)-associated acneiform Rash